Cargando…
Human antibodies targeting ENPP1 as candidate therapeutics for cancers
Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) is a type II transmembrane glycoprotein expressed in many tissues. High expression levels of ENPP1 have been observed in many cancer types such as lung cancer, ovarian cancer, and breast cancer. Such overexpression has been associated with p...
Autores principales: | Chu, Xiaojie, Baek, Du-San, Li, Wei, Shyp, Taras, Mooney, Brian, Hines, Margaret G., Morin, Gregg B., Sorensen, Poul H., Dimitrov, Dimiter S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905232/ https://www.ncbi.nlm.nih.gov/pubmed/36761762 http://dx.doi.org/10.3389/fimmu.2023.1070492 |
Ejemplares similares
-
Human antibody V(H) domains targeting uPAR as candidate therapeutics for cancers
por: Chu, Xiaojie, et al.
Publicado: (2023) -
Human
Antibody V(H) Domains Targeting GPNMB
and VCAM-1 as Candidate Therapeutics for Cancers
por: Chu, Xiaojie, et al.
Publicado: (2023) -
Human Antibody Domains and Fragments Targeting Neutrophil Elastase as Candidate Therapeutics for Cancer and Inflammation-Related Diseases
por: Chu, Xiaojie, et al.
Publicado: (2021) -
Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development
por: Li, Wei, et al.
Publicado: (2017) -
Human monoclonal antibodies as candidate therapeutics against emerging viruses
por: Jin, Yujia, et al.
Publicado: (2017)